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Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and
Secretion. Role of G-Protein Usage
Abstract
Human leukocyte chemoattractant receptors activate chemotactic and cytotoxic pathways to varying
degrees and also activate different G-proteins depending on the receptor and the cell-type. To determine
the relationship between G-protein usage and the biological and biochemical responses activated,
receptors for the chemoattractants formyl peptides (FR), platelet- activating factor (PAFR), and
leukotriene B4 (BLTR) were transfected into RBL-2H3 cells. Pertussis toxin (Ptx) served as a Gα(i)
inhibitor. These receptors were chosen to represent the spectrum of G(i) usage as Ptx had differential
effects on their ability to induce calcium mobilization, phosphoinositide hydrolysis, and exocytosis with
complete inhibition of all responses by FR, intermediate effects on BLTR, and little effect on PAFR. Ptx did
not affect ligand-induced phosphorylation of PAFR and BLTR but inhibited phosphorylation of FR. In
contrast, chemotaxis to formylmethionylleucylphenylalanine, leukotriene B4, and platelet-activating factor
was completely blocked by Ptx. Wortmannin, a phosphotidylinositol 3- kinase inhibitor, also completely
blocked ligand-induced chemotaxis by all receptors but did not affect calcium mobilization or
phosphoinositide hydrolysis; however, it partially blocked the exocytosis response to
formylmethionylleucylphenylalanine and the platelet-activating factor. Membrane ruffling and pseudopod
extension via the BLTR was also completely inhibited by both Ptx and wortmannin. These data suggest
that of the chemoattractant receptors studied, G-protein usage varies with FR being totally dependent on
G(i), whereas BLTR and PAFR utilize both G(i) and a Ptx- insensitive G-protein. Both Ptx-sensitive and
-insensitive G-protein usage can mediate the activation of phospholipase C, mobilization of intracellular
calcium, and exocytosis by chemoattractant receptors. Chemotaxis, however, had an absolute
requirement for a G(i)-mediated pathway.
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Human leukocyte chemoattractant receptors activate
chemotactic and cytotoxic pathways to varying degrees
and also activate different G-proteins depending on the
receptor and the cell-type. To determine the relationship between G-protein usage and the biological and
biochemical responses activated, receptors for the chemoattractants formyl peptides (FR), platelet-activating
factor (PAFR), and leukotriene B4 (BLTR) were transfected into RBL-2H3 cells. Pertussis toxin (Ptx) served
as a Gai inhibitor. These receptors were chosen to represent the spectrum of Gi usage as Ptx had differential
effects on their ability to induce calcium mobilization,
phosphoinositide hydrolysis, and exocytosis with complete inhibition of all responses by FR, intermediate
effects on BLTR, and little effect on PAFR. Ptx did not
affect ligand-induced phosphorylation of PAFR and
BLTR but inhibited phosphorylation of FR. In contrast,
chemotaxis to formylmethionylleucylphenylalanine,
leukotriene B4, and platelet-activating factor was completely blocked by Ptx. Wortmannin, a phosphotidylinositol 3-kinase inhibitor, also completely blocked ligand-induced chemotaxis by all receptors but did not
affect calcium mobilization or phosphoinositide hydrolysis; however, it partially blocked the exocytosis response to formylmethionylleucylphenylalanine and the
platelet-activating factor. Membrane ruffling and pseudopod extension via the BLTR was also completely inhibited by both Ptx and wortmannin. These data suggest
that of the chemoattractant receptors studied, G-protein usage varies with FR being totally dependent on Gi,
whereas BLTR and PAFR utilize both Gi and a Ptxinsensitive G-protein. Both Ptx-sensitive and -insensitive G-protein usage can mediate the activation of phospholipase C, mobilization of intracellular calcium, and
exocytosis by chemoattractant receptors. Chemotaxis,
however, had an absolute requirement for a Gi-mediated
pathway.

Migration of leukocytes to sites of inflammation is mediated
via the activation of G-protein-coupled chemoattractant receptors (1, 2). Chemoattractants at low concentrations elicit shape
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change, pseudopod extension, and chemotaxis, and at higher
doses; many of them also trigger degranulation and generation
of superoxide anions (1, 3). Pathways leading to these activities
have been shown to have different dose requirements, kinetics
and regulation (4, 5), but the role of G-protein usage remains
unknown.
Formylpeptides (fMLP),1 platelet-activating factor (PAF),
and leukotriene B4 (LTB4) are potent chemoattractants for
neutrophils and to varying degrees also activate exocytosis and
generation of superoxide anions (3, 4, 6). These activities are
mediated through G-protein-coupled receptors (FR, PAFR, and
BLTR) (2, 7). G-protein usage of chemoattractant receptors was
known to be different depending on cell types (1, 8 –10). Previous studies in RBL cells indicated that FR activated Gi,
whereas PAFR utilized both Gi and a Ptx-insensitive G-protein
to activate phosphoinositide hydrolysis, calcium mobilization,
and exocytosis (11, 12). However, the G-protein usage requirements for activating chemotaxis versus exocytosis in these cells
were unknown. Therefore, we sought to determine the relationship between G-protein usage versus the subsequent responses
activated by these receptors in a single cell line viz. RBL-2H3
cells. Epitope-tagged BLTR, FR, and PAFR were expressed in
RBL-2H3 cells, and inhibitors of signaling through Gi proteins
(Ptx) and the PI3 kinase pathway (wortmannin) were used to
determine the role of these pathways in pseudopod extension,
chemotaxis, phospholipase C activation, calcium mobilization,
and exocytosis. These data demonstrate distinct G-protein usage among chemoattractant receptors and suggest that a Gimediated pathway, presumably involving bg and PI3 kinase, is
required for motility-related functions. On the other hand,
stimulation of phospholipase C activity, calcium mobilization,
and exocytosis can be mediated through activation of a Ptxinsensitive G-protein as well as through Gi.
EXPERIMENTAL PROCEDURES

Materials—[32P]Orthophosphate (8500 –9120 Ci/mmol), myo-[2-3H]inositol (24.4 Ci/mmol), and [3H]leukotriene B4 (200 Ci/mmol) were
purchased from NEN Life Science Products. LTB4 was obtained from
Cayman Chemicals. Rat tail collagen was obtained from Collaborative
Biomedicals, 25 3 80 mm 8 m pore size polycarbonate filters are from
Neuroprobe, and the Leukostat staining kit was obtained from Fisher.
All other materials were obtained from sources previously described
(12).
Construction of Epitope-tagged BLTR—Nucleotides encoding a nine
amino acid hemagluttinin-epitope sequence (YPYDVPDYA) are in-

1
The abbreviations used are: fMLP, formylmethionylleucylphenylalanine; BLTR, leukotriene B4 receptor; LTB4, leukotriene B4; RBL, rat
basophilic leukemia; PAF, platelet-activating factor; Ptx, pertussis toxin; PI3 kinase, phosphotidylinositol 3-kinase; FR, formyl receptor;
PAFR, platelet-activating factor receptor.
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FIG. 1. Effect of pertussis toxin on chemoattractant receptor
phosphorylation. RBL cells expressing the indicated receptors were
incubated overnight with (lanes 4, 5, and 6) or without (lanes 1, 2, and
3) Ptx (100 ng/ml). The cells were then 32P-labeled (3 3 106 cells/60-mm
dish) and stimulated with cognate ligands (1.0 mM LTB4, 1.0 mM fMLP,
100 nM PAF) as indicated (lanes 2 and 5) or phorbol 12-myristate
13-acetate (PMA) (lanes 3 and 6) for 5 min. Cells were lysed and
immunoprecipitated with 12CA5 antibody and analyzed by SDS-polyacrylamide gel electrophoresis and autoradiography. Results shown are
representative of at least three independent experiments.
serted between the N-terminal initiator methionine and the second
amino acid of human BLTR by polymerase chain reaction methods as
described previously for other chemoattractant receptors with minor
changes in polymerase chain reaction conditions (12, 13). Because of
high GC content of the DNA encoding the carboxyl-terminal third of the
BLTR, cDNA polymerase chain reaction amplification occurred only in
reactions containing 10% dimethyl sulfoxide (Me2SO). The integrity of
the epitope tag as well as the rest of the molecule was verified by
dideoxy sequencing after cloning into eukaryotic expression vector
PRK-5. In BLTR a single nucleotide change resulted in a conservative
substitution of amino acid 87 (Leu 3 Met). Competition ligand binding
experiments and calcium mobilization studies indicated an affinity for
LTB4 (Kd 4.4 6 0.63 nM) comparable to that seen in neutrophils and in
other BLTR-transfected cell lines (7). In some experiments, i.e. calcium
mobilization, RBL cells expressing a clone without this point mutation
showed identical results.
Cell Culture, Transfection, Phosphoinositide Hydrolysis, Ca21 Mobilization, and Phosphorylation—We previously isolated RBL cells stably
expressing FR and PAFR, and cells expressing BLTR were prepared
following essentially the same procedures (11, 12). Methods for RBL2H3 culture, transfection and clonal selection, phosphoinositide hydrolysis, calcium mobilization, 32P labeling, and immunoprecipitation of
epitope-tagged receptors were essentially as described previously. (12)
Chemotaxis—Migration of RBL stable transfectants was measured
by a 48-well micro-chemotaxis chamber technique as described (14).
Polycarbonate filters (25 3 80 mm 8 m pore size Neuroprobe) were
coated with 50 mg/ml of rat type I collagen (Collaborative Biomedicals)
in HEPES-buffered RPMI 1640 medium for 2 h at 37 °C. A dry coated
filter was placed on a 48-well chamber containing different amounts of
LTB4, fMLP, or PAF. RBL cells expressing the corresponding receptors
(5 3 104/well) were added to the top wells, and the chamber was
incubated at 37 °C in 5% CO2 for 4 h. Cells migrating to the underside
of the filter were fixed using a leukostat staining kit. Cells from four
high power (400X) fields representing at least two independent wells for
each concentration of ligand were counted. Chemokinesis, measured
with ligand at same concentration in both chambers, was less than 15%
of the directed migration.
Micromanipulation—Cell micromanipulation was performed as described elsewhere (15). Briefly, the cells were added to a thermostated
chamber, which was 2 mm thick and open from both sides to allow
micromanipulation. The experiments were performed at 30 °C 15 min
after removing the cells from the culture dishes. To prevent nonspecific
cell activation, the bottom of the chamber was coated with collagen.
After adding the cells to the experimental chamber a single cell was
chosen and held with a collagen-coated pipette. A local region of the
membrane of the chosen cell was exposed for 5 min to a solution
containing 10 nM LTB4, which was delivered from another pipette. The
cell was observed with an inverted microscope Nikon 200 with 603 oil

FIG. 2. Effect of pertussis toxin and wortmannin on calcium
mobilization. Calcium mobilization was measured in BLTR, FR, or
PAFR expressing RBL cells treated with Ptx (100 ng/ml overnight) or
wortmannin (100 nM for 3 h) as indicated, and compared with untreated
(Control) cells. Representative traces from at least five independent
measurements are shown.
immersion objective. The microscope images were recorded using a
COHU CCD camera.
RESULTS

Functional Expression of LTB4 Receptor in RBL-2H3 Cells—
Several chemoattractant receptors including FR and PAFR
were previously expressed in RBL-2H3 cells for functional and
regulation studies (11, 12). Native RBL cells did not express
any LTB4 receptors as determined by lack of calcium mobilization to 1.0 mM LTB4. To determine the signal transduction
pathways activated by LTB4 receptors, they were stably expressed in transfected clonal lines of RBL cells (BLTR). These
receptors induced calcium mobilization, inositol phosphate production, exocytosis, and chemotaxis (see below) in RBL cells.
Competition ligand binding experiments indicated an affinity
for LTB4 (Kd 4.4 6 0.63 nM) comparable to that seen in neutrophils and in other BLTR-transfected cell lines (7)
Phosphorylation of Chemoattractant Receptors—LTB4 and
phorbol 12-myristate 13-acetate stimulated the phosphorylation of BLTR by severalfold (Fig. 1A, lanes 1–3). As the cDNA
is predicted to encode a 35-kDa protein, the two phosphoprotein bands at 40 and 60 kDa likely represent distinct glycosylation of the receptor. Previous studies showed that both FR
and PAFR also displayed ligand-induced phosphorylation,
whereas phosphorylation of PAFR but not FR was stimulated
by phorbol 12-myristate 13-acetate (11, 12). Pertussis toxin
(16), an inhibitor of signaling through Gi and Go family of
G-proteins, did not have any effect on ligand or phorbol 12myristate 13-acetate-induced phosphorylation of BLTR (Fig.
1A) or PAFR (Fig. 1C). In contrast, fMLP-induced phosphorylation of FR was significantly inhibited by Ptx (Fig. 1B).
Distinct Pathways for Chemotaxis and Exocytosis—The ef-
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FIG. 3. Effect of pertussis toxin and wortmannin on generation of total inositol phosphates (IP) and exocytosis. RBL cells expressing
BLTR (A), FR (B), or PAFR (C) cultured overnight in the presence of [3H]inositol (1.0 mCi/ml) were left untreated (open circles), pretreated overnight
with 100 ng/ml Ptx (closed squares), or pretreated for 3 h with 100 nM wortmannin (closed triangles) and stimulated with different concentrations
of LTB4, fMLP, or PAF as indicated. Total inositol phosphate generation was determined as described previously (12). The experiment was repeated
three times with similar results. Ligand-induced secretion of b-hexoseaminidase (D, E, and F) was determined in cells left untreated (open circles),
pretreated overnight with 100 ng/ml Ptx (closed squares), or pretreated for 3 h with 100 nM wortmannin (closed triangles) as described previously
(12). The data are expressed as percentage of total b-hexoseaminidase present in cells. Data are mean 6 S.E. of a single representative of three
experiments performed in triplicate.
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fects of Ptx and the PI3-kinase inhibitor wortmannin (17) on
ligand-induced calcium mobilization (Fig. 2), phosphoinositide
hydrolysis, exocytosis (Fig. 3), and chemotaxis (Fig. 4) were
measured to determine the differential regulation of these responses. For BLTR, Ptx did not have a significant effect on the
initial spike of calcium release but the length of the response
was diminished (Fig. 2A). Whereas FR-induced calcium mobilization was completely inhibited by Ptx, it did not affect the
initial spike or sustained calcium mobilization by PAFR (Fig. 2,
B and C). A similar differential effect of Ptx was also seen in
phosphotidylinositol hydrolysis and exocytosis responses of
these three receptors. Whereas the responses of FR were completely inhibited, BLTR showed some resistance to inhibition
by Ptx and about 50% of the PAFR responses were Ptx-resistant (Fig. 3). Wortmannin had no effect on calcium mobilization
by BLTR, FR, or PAFR (Fig. 2) and also did not inhibit phosphotidylinositol hydrolysis (Fig. 3). Wortmannin did not affect
the exocytosis by BLTR but partially inhibited these responses
to FR and to low concentrations of PAF. In contrast to these
differences, chemotaxis to fMLP, PAF, and LTB4 was completely inhibited by Ptx (Fig. 4). Wortmannin also inhibited
chemotaxis to a similar extent (;90%) for all three receptors
(Fig. 4).
Micromanipulation of RBL-BLTR Cells—Cytoskeletal alterations and pseudopod formation in the direction of the source of
chemoattractant are essential events in leukocyte migration
(18). To better define the role of distinct signaling events in
leukocyte chemotaxis, ligand-induced membrane ruffling and
pseudopod formation were studied using the micromanipulation assay (Fig. 5) (15, 19). A pipette held a single cell, and a
region of its body was exposed to 10 nM LTB4 blown continuously from a second pipette. The local exposure of the cell
surface to chemoattractant provided a condition for the formation of a single pseudopod-like structure in suspension (Fig.
5a). Incubation of cells with Ptx (Fig. 5b) or wortmannin (Fig.
5c) resulted in complete inhibition of LTB4-induced pseudopod
formation. However, Ptx-treated cells spread on culture dishes
when replated (data not shown) indicating that they retain
their ability to extend lamellipodia during physical attachment
but were unable to respond to LTB4 activation. They also
displayed spontaneous activation and membrane ruffles (6 of
10 cells) at other sites on the cell body distinct from the area of
stimulation by the second pipette. Cells treated with wortmannin also failed to extend a pseudopod-like structure. However,
many of these cells showed a partial response and extended
several membrane ruffles at the site of stimulation (7 of 10
cells) as shown in Fig. 5c.
DISCUSSION

Expression of chemoattractant receptors that activate different G-proteins in a single cell line allowed the determination of
the role of specific G-proteins in activating distinct biological
responses. The data show that chemoattractant receptors may
activate phospholipase C, calcium mobilization, and exocytosis
through multiple G-proteins, but ligand-stimulated pseudopod
extension and chemotaxis require the activation of a Ptx-sensitive G-protein and PI3 kinase.
Comparison of biochemical responses activated by FR,
BLTR, and PAFR, all of which activate Gi, but couple to varying degrees to a Ptx-insensitive G-protein, allowed clear distinctions to be made for the role of G-proteins in different
activities. Previous studies have indicated that receptor occupancy, but not signaling through G-proteins, is essential for
receptor phosphorylation (20, 21). Whereas the PAFR and
BLTR were phosphorylated to similar levels in Ptx-treated
cells, FR phosphorylation was inhibited. These data suggest
that FR is likely phosphorylated by G-protein-coupled receptor

FIG. 4. Effect of pertussis toxin and wortmannin on chemotaxis. Ligand-dependent chemotaxis was measured in control cells
(open circles), cells treated overnight with 100 ng/ml Ptx (closed
squares), or cells treated with 100 nM wortmannin (closed triangles) 10
min prior to the start of chemotaxis assay as described under “Experimental Procedures.” Data are the mean 6 S.E. from four individual
fields for each concentration from a representative experiment from at
least three repetitions.

kinases GRK2 or GRK3, because both require free bg for translocation to membrane and activation (20). Studies on in vitro
phosphorylation of the C terminus of FR also support this
contention (22). Lack of any affect, by Ptx, on ligand-induced
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FIG. 5. Pseudopod formation by BLTR RBL cells. Formation of a
pseudopod was stimulated by a local exposure of the cell surface to
LTB4. A small pipette was filled with 1028 M solution of LTB4 and was
positioned close to the cell surface; blowing pressure of 20 pascal was
applied. The cells observed for 5 min with an inverted microscope and
images were recorded in real time using COHU CCD camera. a, untreated cells; b, cells treated overnight with 100 ng/ml Ptx; c, cells
treated with 100 nM of wortmannin for 3 h.

receptor phosphorylation of PAFR and BLTR indicates that
signal transduction through the Ptx-sensitive G-protein is not
required for this event.
Previous studies in neutrophils and in transfected cell lines
indicated that all FR responses are completely Ptx-sensitive (1,
11, 23). In contrast, both PAFR and BLTR can activate Ptxinsensitive G-proteins as well as Gi (7, 23, 24). Our previous
observations in RBL cells showed that calcium mobilization
was only marginally affected and phosphotidylinositol hydrolysis was partially inhibited by Ptx, which suggests that PAFR
activate a Ptx-insensitive G-protein in RBL cells (12). PAFR
activated sufficient levels of Ptx-insensitive G-protein in these
cells to cause exocytosis. The current studies show that like
PAFR, BLTR expressed in RBL cells could utilize a Ptx-insensitive G-protein to activate phosphotidylinositol hydrolysis and
mobilize intracellular calcium. However, the most significant
finding of the current study is that despite activating different
G-proteins all three receptors displayed an absolute requirement for Gi to activate chemotaxis. This suggests that signal
transduction pathways activated through Ptx-insensitive Gproteins are not sufficient, and the activation of a Gi-mediated
event is essential for chemotaxis. Recent studies also indicate
that bg-mediated responses are essential for cell migration
(25–27). The data presented herein indicates that this bg must
come from the activation of a Ptx-sensitive G-protein, presumably Gi. The bg released from a Ptx-insensitive G-protein by
the same chemoattractant receptor was not sufficient for
chemotaxis.
The single cell manipulation assay has provided a means to
correlate biochemical and motility-related cellular responses.
The ability of RBL cells to extend a pseudopod similar to the
one produced by leukocytes suggests molecular events in the
migration of leukocytes and transfected RBL cells are related
(19). Whereas cell lines of non-lymphoid origin like Chinese
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hamster ovary cells and HEK 293 cells also undergo chemotaxis (7, 25), it is not known whether they use similar pathways
or cytoskeletal processes as leukocytes for migration. In wortmannin-treated RBL cells, the low level of chemotactic responsiveness was associated with weak membrane ruffling and no
pseudopod extension (Fig. 5). These results again underscore
the dissociation of chemotaxis from the calcium release and
exocytosis, which remain unaffected by wortmannin.
The unique biochemical pathways activated by the bg subunits of Gi proteins that mediate chemotaxis are at present
unknown. The bg induced PI3 kinase activity, and its related
signaling pathway could be one of these events (28 –30). Other
studies also indicated that GTPgS could activate actin polymerization in soluble cell extracts of leukocytes in the presence of
the low molecular weight G-protein CDC42 but not Rho or Rac
(31, 32). Therefore it is possible that bg dimers released from
Gi, but not the Gq family of G-proteins, activate one or more low
molecular weight G-proteins that may participate in leukocyte
migration. In any case, the data clearly demonstrate that chemoattractant receptors may couple to individual or multiple
G-proteins. To stimulate chemotaxis however, they must activate Gi. Moreover, distinct signaling pathways among G-proteins are likely to determine other cellular responses initiated
by chemoattractant receptors. These data may explain numerous observations in neutrophils and other cells that different
chemoattractant receptors display different abilities to trigger
nonmotility-related functions (i.e. respiratory burst, mitogenesis) despite exhibiting similar chemotactic responses (1, 23).
The availability of a model system in which migration responses may be measured both at population and single cell
levels will allow further investigation of the divergent pathways for motility and cytotoxic functions.
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